Assessment of Blood Glucose Level and Lipid Profiles among Hormonal Contraceptive Users in Ayder Comprehensive Specialized Hospital, Tigray, Northern Ethiopia, 2024

Abstract

Hormonal contraceptives have been observed to affect and induce changes in blood glucose level and lipid profiles. Studies have been shown that hormonal contraceptive is suggested to trigger changes in blood glucose level and lipid profiles.To assess blood glucose level and lipid profile among hormonal contraceptive users at Ayder Comprehensive Specialized Hospital, Tigray, Northern Ethiopia, 2023/2024. Comparative cross-sectional study design was carried out on 57 hormonal contraceptive users and 57 age-matched non-users, in Ayder Comprehensive Specialized Hospital from July 2023 to October 2024. Fasting blood samples for the estimation of TC, TG, HDL-c, LDL-c and FBS levels were collected. Data was entered using Epi-data software version 4.5 and analyzed using SPSS software version 25. Student's independent t-test was used to compare the results. A one-way ANOVA was used to identify the variation in the lipid profile and FBS between oral contraceptive pills, DMPAs and implant users. Simple linear regression was used to determine the changes in blood glucose and lipid profile in relation to the duration of hormonal contraceptive use. The mean serum levels of TC, TG, LDL-c, and FBS were significantly greater in hormonal contraceptive users than in non-users (P =0.005, P =0.000, P =0.003, and P =0.012, respectively), and the mean serum HDL-c level was significantly lower than that in controls (P =0.002). The mean serum levels of TG, LDL-c, and HDL-c were significantly different between DMPA, implant, and OCP users (P =0.000, P =0.031, and P =0.001, respectively). Compared with OCP and implant users, DMPA users had the highest mean serum levels of TC, TG, and LDL-c but had the lowest mean serum levels of HDL-c. As the duration of oral contraception and DMPA use increased the serum levels of TG and LDL-c increased (P = 0.017 and P = 0.014 respectively), whereas the serum level of HDL-c decreased (P = 0.01). The serum levels of LDL-c increased as the duration of implant use increased (p = 0.017). As the duration of DMPA use increases, the serum level of FBS moderately increases (p =0.000). Over all, hormonal contraceptive use results in changes in the mean serum lipid profile and FBS level. DMPA produces more change on mean serum lipid profiles and FBS than the other types are, and implants have a minimal effect on the level of all lipid profiles.